Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals that elevated FLOX scores predict nasal cannula failure in immunocompromised children, indicating early risk assessment can guide intubation decisions.
Background Heated, humidified, high‐flow nasal cannula (HFNC) before intubation has been associated with increased mortality in children with immunocompromising conditions (ICC). Objectives We sought to describe HFNC failure (intubation) rate and aimed to develop a novel score associated with HFNC failure. Methods This is a single center, retrospective cohort. Patients (aged 0–26 years) with ICCs who used HFNC between 2021 and 2023 were included. Results Forty‐four (47.3%) of 93 included subjects failed HFNC. PICU mortality was 14% ( n = 13). The median duration of HFNC was 18.7 h (IQR: 6.0, 40.4). We developed the novel FLOX ((flow in Liters/minute)/weight (kg)*FiO 2 ) score. Median FLOX score was higher with HFNC failure at initiation ( p = 0.04), 2 h ( p = 0.03), 4 h ( p = 0.05), and 6 h ( p = 0.05). Adjusting for acuity, the odds of HFNC failure with a FLOX score (≥0.20) were as follows: Initiation OR = 2.5 (95%CI: 1.03, 5.9), p = 0.042); 2 h of HFNC, OR = 4.3 ((95%CI: 1.7, 10.9), p = 0.002); 4 h of HFNC, OR = 6.5 (95%CI: 2.5, 16.8), ( p < 0.001); and 6 h of HFNC, OR = 4.9 (95%CI: 1.9, 12.7), ( p = 0.001). Conclusion In children with ICCs, almost half fail HFNC. Mortality was high in those who fail HFNC. The FLOX score, specifically a FLOX ≥ 0.20 is associated with increased odds of failing HFNC in our ICC cohort.
No takes yet. Share an insight, caveat, or question.
Mai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: